Immunexpress is a company creating molecular diagnostics for sepsis. Its SeptiCyte technology quantifies the specific molecular biomarkers, which capture signals from a patient's immune system in response to infection and hold the key to early detection of sepsis, as well as guiding the use and timing of drugs and other therapies.